Immunomedics Inc. | Mutual Funds
Mutual Funds that own Immunomedics Inc.
Fidelity Select Biotechnology Portfolio
5,339,383
2.86%
-1,118,500
1.55%
07/31/2018
T Rowe Price Health Sciences Fund
3,886,825
2.08%
732,989
0.82%
06/30/2018
Vanguard Total Stock Market Index Fund
3,828,749
2.04%
33,544
0.01%
07/31/2018
Vanguard Small Cap Index Fund
3,823,116
2.04%
47,345
0.11%
07/31/2018
SPDR S&P Biotech ETF
3,037,332
1.63%
7,815
1.39%
09/06/2018
T Rowe Price New Horizons Fund
2,857,314
1.53%
264,676
0.31%
06/30/2018
iShares Russell 2000 ETF
2,784,342
1.49%
-1,488
0.15%
09/06/2018
Vanguard Small Cap Growth Index Fund
2,181,696
1.17%
31,453
0.23%
07/31/2018
Vanguard Extended Market Index Fund
2,126,119
1.13%
26,980
0.08%
07/31/2018
iShares Nasdaq Biotechnology ETF
1,935,523
1.04%
-25,305
0.53%
09/06/2018
| Address |
300 The American Road
Morris Plains New Jersey 07950
United States
|
|
Employees
|
- |
| Website |
http://www.immunomedics.com |
| Updated |
07/08/2019 |
| Immunomedics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of researching, developing, manufacturing and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. It operates through the United States, and Europe geographical segments. |
